NCT05429203

Brief Summary

The purpose of the study is to compare the success rates of procedure success and complication rates in patients undergoing Endoscopic retrograde cholangiopancreatography (ERCP) using two types of currently available endoscopes. These are (1) duodenoscope with a Single-use distal cover or (2) a conventional reusable duodenoscope.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
319

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 17, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 23, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

October 25, 2022

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 29, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 29, 2024

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

September 15, 2025

Completed
Last Updated

September 15, 2025

Status Verified

August 1, 2025

Enrollment Period

1.8 years

First QC Date

June 17, 2022

Results QC Date

July 15, 2025

Last Update Submit

August 25, 2025

Conditions

Keywords

ERCPDuodenoscopeDuodenoscope with single-use distal cover

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Procedure-related Adverse Events

    Patients undergoing Endoscopic retrograde cholangiopancreatography (ERCP) using either of the 2 duodenoscopes were assessed for superficial mucosal injury, perforation of the stomach or intestine, mucosal bleeding, pancreatitis, infection, death or any other symptom reported by the patient.

    3 months

Secondary Outcomes (12)

  • Duodenoscope Maneuverability: Intubation Into Esophagus

    Maneuverability will be assessed only during the procedure (approximately 10 minutes)

  • Duodenoscope Maneuverability: Passage Into Stomach

    Maneuverability will be assessed only during the procedure (approximately 10 minutes)

  • Duodenoscope Maneuverability: Navigation Across Pylorus

    Maneuverability will be assessed only during the procedure (approximately 10 minutes)

  • Duodenoscope Maneuverability: Achieving Short Position of the Scope

    Maneuverability will be assessed only during the procedure (approximately 10 minutes)

  • Duodenoscope Maneuverability: Achieving Optimal Papillary Position

    Maneuverability will be assessed only during the procedure (approximately 10 minutes)

  • +7 more secondary outcomes

Study Arms (2)

Duodenoscope with single-use distal cover

ACTIVE COMPARATOR

Patients will undergo ERCP using a duodenoscope with a single-use distal cover

Device: Duodenoscope with single-use distal cover

Conventional Duodenoscope

ACTIVE COMPARATOR

Patients will undergo ERCP using a conventional duodenoscope

Device: Conventional duodenoscope

Interventions

Newer duodenoscope with a single-use distal cover

Duodenoscope with single-use distal cover

Conventional duodenoscope with standard methods of reprocessing

Conventional Duodenoscope

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing ERCP for biliary and pancreatic conditions
  • Age \> 18 years old

You may not qualify if:

  • Vulnerable patient groups including pregnant women
  • Patients who are unable to consent
  • Patients with known cholangitis
  • Patients with known Carbapenem-Resistant Enterobacteriaceae (CRE) or any other multi-drug resistant organisms (MDRO) infection
  • Surgically altered anatomy except for Billroth I

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford hospital

Palo Alto, California, 943305, United States

Location

Related Publications (1)

  • Bang JY, Rosch T, Kim HM, Thakkar S, Robalino Gonzaga E, Tharian B, Inamdar S, Lee LS, Yachimski P, Jamidar P, Muniraj T, DiMaio C, Kumta N, Sethi A, Draganov P, Yang D, Seoud T, Perisetti A, Bondi G, Kirtane S, Hawes R, Wilcox CM, Kozarek R, Reddy DN, Varadarajulu S. Prospective evaluation of an assessment tool for technical performance of duodenoscopes. Dig Endosc. 2021 Jul;33(5):822-828. doi: 10.1111/den.13856. Epub 2020 Nov 17.

    PMID: 33007136BACKGROUND

MeSH Terms

Conditions

Gallbladder DiseasesPancreatic DiseasesCholedocholithiasisBiliary Tract NeoplasmsPancreatic Neoplasms

Interventions

Duodenoscopes

Condition Hierarchy (Ancestors)

Biliary Tract DiseasesDigestive System DiseasesCommon Bile Duct DiseasesBile Duct DiseasesCholelithiasisDigestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Endoscopes, GastrointestinalEndoscopesDiagnostic EquipmentEquipment and SuppliesSurgical Equipment

Results Point of Contact

Title
Subhas Banerjee, MD
Organization
Stanford University

Study Officials

  • Subhas Banerjee, MD

    Stanford University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

June 17, 2022

First Posted

June 23, 2022

Study Start

October 25, 2022

Primary Completion

July 29, 2024

Study Completion

July 29, 2024

Last Updated

September 15, 2025

Results First Posted

September 15, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations